Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
This beginner guide shows you how to set up a zero-based budget step by step, ensuring every dollar has a job and your spending stays on track.
18,523 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
In a volatile market, the dividend growth approach that emphasizes rising payouts over big yields is drawing attentio...
NuScale Power faces a high-stakes decade as regulators, financiers, and utilities weigh SMR potential. This article l...
Five of america's biggest banks kick off a pivotal earnings week. Here's what to watch as each reports and how the re...
Navitas Semiconductor sits at the crossroads of faster charging and smarter energy use. This article maps possible pa...
IBM is attracting fresh investor attention as its AI infrastructure strategy gains traction. Arvind Krishna’s reshape...
A Florida federal court has upheld FinCEN’s anti-money laundering rule governing residential real estate transfers, e...
A yen-hedged approach to Japan equities outperformed the unhedged EWJ by roughly six percentage points in the first h...
Friday brought a notable rally for Integer Holdings as earnings beat and optimistic analyst updates boosted sentiment...
In 2026, four Dividend Kings are outperforming the S&P 500 as investors pivot to cash-flow creators. The move signals...
A close look at on-chain data shows Vitalik Buterin holding roughly 240,000 ETH, with recent large withdrawals and a ...
GPIQ carries the lowest fee in the Nasdaq-100 income ETF group, at 0.29%, intensifying the debate over cost versus yi...